Literature DB >> 8087423

Expression of epidermal growth factor receptor changes in the hypothalamus during the onset of female puberty.

Y J Ma1, D F Hill, M P Junier, M E Costa, S E Felder, S R Ojeda.   

Abstract

Recent findings have led to the concept that transforming growth factor alpha (TGF alpha) contributes to the neuroendocrine regulation of female puberty by stimulating the release of luteinizing hormone-releasing hormone (LHRH), the neurohormone controlling sexual development. It was postulated that this effect is mediated by epidermal growth factor receptors (EGFR) and that EGFR may not be located on LHRH neurons, so that TGF alpha-induced LHRH release would require an intermediate cell-to-cell interaction, presumably of glial-neuronal nature. The present study was undertaken to characterize the presence of EGFR in rat hypothalamus and to determine if changes in EGFR gene expression and EGFR protein occur at the time of puberty. RNA blot hybridization demonstrated that the hypothalamus expresses all mRNA species known to encode EGFR. RNase protection assays revealed that alternative splicing of the EGFR primary mRNA transcript occurs in the hypothalamus and produces a predominant transcript encoding the full-length EGFR and a much less abundant, shorter mRNA encoding a truncated, and presumably secreted form of EGFR. EGFR-like immunoreactive material was found in several hypothalamic regions including the organum vasculosum of the lamina terminalis, supraoptic, suprachiasmatic, and paraventricular nuclei, ependymal cells lining the third ventricle, some astrocytes associated with blood vessels, astrocytes of the pial surface, and tanycytes and glial cells of the median eminence (ME). Low levels of EGFR mRNA were detected by hybridization histochemistry in cells of the same areas containing EGFR-like immunoreactivity. Double-immunohistochemistry revealed that even though LHRH neurons are in close proximity to EGFR-positive cells, they do not contain EGFR. In the ME, EGFR-immunonegative LHRH nerve terminals tightly coexist with EGFR-positive cells, presumably tanycytes and glial astrocytes. EGFR mRNA levels measured by quantitative reverse transcription-polymerase chain reaction assay (RT-PCR) in the ME-arcuate nucleus region at the time of puberty decreased in the morning of the first proestrus, i.e., preceding the first preovulatory surge of gonadotropins, and rebounded at the time of the surge. Functional EGFR protein levels, detected by the ability of the receptor to autophosphorylate in response to ligand or divalent antibody-induced activation, changed in a similar manner at the time of puberty. No such changes were observed in the cerebellum, a brain region irrelevant to neuroendocrine reproductive control. These results demonstrate the existence of EGF receptors in the prepubertal female rat hypothalamus and suggest that changes in EGFR gene expression and biologically active EGFR protein contributes to the neuroendocrine process underlying the first preovulatory surge of gonadotropins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087423     DOI: 10.1006/mcne.1994.1029

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  23 in total

1.  Prepubertal ethanol exposure alters hypothalamic transforming growth factor-α and erbB1 receptor signaling in the female rat.

Authors:  Vinod K Srivastava; Jill K Hiney; W Les Dees
Journal:  Alcohol       Date:  2010-10-06       Impact factor: 2.405

2.  Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain.

Authors:  Alejandro Lomniczi; Anda Cornea; Maria E Costa; Sergio R Ojeda
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

3.  Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression?

Authors:  M E Wierman; X Xiong; J K Kepa; A J Spaulding; B M Jacobsen; Z Fang; G Nilaver; S R Ojeda
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 4.  Expression and function of ErbB receptors and ligands in the pituitary.

Authors:  Odelia Cooper; George Vlotides; Hidenori Fukuoka; Mark I Greene; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2011-10-27       Impact factor: 5.678

Review 5.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

6.  An increase in in vivo release of LHRH and precocious puberty by posterior hypothalamic lesions in female rhesus monkeys (Macaca mulatta).

Authors:  Bret M Windsor-Engnell; Etsuko Kasuya; Masaharu Mizuno; Kim L Keen; Ei Terasawa
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-12-05       Impact factor: 4.310

7.  Manganese protects against the effects of alcohol on hypothalamic puberty-related hormones.

Authors:  Jill K Hiney; Vinod K Srivastava; William L Dees
Journal:  Life Sci       Date:  2016-02-11       Impact factor: 5.037

8.  Reproductive hormone-dependent and -independent contributions to developmental changes in kisspeptin in GnRH-deficient hypogonadal mice.

Authors:  John C Gill; Oulu Wang; Shelley Kakar; Enzo Martinelli; Rona S Carroll; Ursula B Kaiser
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

9.  Estradiol enhances prostaglandin E2 receptor gene expression in luteinizing hormone-releasing hormone (LHRH) neurons and facilitates the LHRH response to PGE2 by activating a glia-to-neuron signaling pathway.

Authors:  F Rage; B J Lee; Y J Ma; S R Ojeda
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

10.  A role for transforming growth factor alpha as an inducer of astrogliosis.

Authors:  A G Rabchevsky; J M Weinitz; M Coulpier; C Fages; M Tinel; M P Junier
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.